Paragon Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,731
| Closed | -$2.98M | – | 91 |
|
|
2024
Q4 | $2.98M | Sell |
5,731
-41
| -0.7% | -$21.3K | 1.02% | 31 |
|
|
2024
Q3 | $3.57M | Buy |
5,772
+73
| +1% | +$45.2K | 1.16% | 26 |
|
|
2024
Q2 | $3.15M | Buy |
5,699
+546
| +11% | +$302K | 1.15% | 28 |
|
|
2024
Q1 | $3M | Buy |
5,153
+1,115
| +28% | +$648K | 1.21% | 25 |
|
|
2023
Q4 | $2.14M | Buy |
4,038
+138
| +4% | +$73.3K | 0.91% | 23 |
|
|
2023
Q3 | $1.97M | Sell |
3,900
-2,800
| -42% | -$1.42M | 0.82% | 29 |
|
|
2023
Q2 | $3.5M | Buy |
6,700
+1,955
| +41% | +$1.02M | 1.13% | 17 |
|
|
2023
Q1 | $2.74M | Sell |
4,745
-651
| -12% | -$375K | 0.92% | 26 |
|
|
2022
Q4 | $2.97M | Sell |
5,396
-906
| -14% | -$499K | 1.31% | 24 |
|
|
2022
Q3 | $3.2M | Buy |
6,302
+2,465
| +64% | +$1.25M | 1.63% | 18 |
|
|
2022
Q2 | $2.08M | Sell |
3,837
-718
| -16% | -$390K | 1.04% | 30 |
|
|
2022
Q1 | $2.69M | Buy |
4,555
+1,036
| +29% | +$612K | 1.13% | 24 |
|
|
2021
Q4 | $2.35M | Buy |
+3,519
| New | +$2.35M | 1.15% | 24 |
|